Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Go back to Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results| (NASDAQ: VIR) | Delayed: 9.57 +0.41 (4.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.16 | 52 Week High | $ | |||
| Open | $9.29 | 52 Week Low | $ | |||
| Day High | $9.63 | P/E | N/A | |||
| Day Low | $9.16 | EPS | $ | |||
| Volume | 1,792,342 | |||||

